DOCS huge base breakout with very strong momentum NYSE:DOCS
DOCS huge base breakout with very strong momentum
Good volumes too.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.08 USD
147.58 M USD
475.42 M USD
129.67 M
About Doximity, Inc.
Sector
Industry
CEO
Jeffrey A. Tangney
Website
Headquarters
San Francisco
Founded
2010
FIGI
BBG0026ZJQX7
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
Breaking: Doximity Stock Jumps 37% On Upbeat Annual OutlookDoximity Inc. (NASDAQ: DOCS), the leading digital platform for U.S. medical professionals, has made headlines with its stock skyrocketing 37% following a stellar earnings report and an upbeat annual outlook. The company’s third-quarter fiscal 2025 results not only surpassed analyst expectations but
Doximity Is Preparing To Report Another Strong QuarterKey arguments supporting the idea
• Doximity is a leader in the rapidly growing telemedicine industry.
• The results for Q3 FY2025 may once again impress investors due to the use
of AI tools.
• Maintaining high growth rates of financial indicators and a strong balance
sheet in the medium term.
New Setup: DOCSDOCS : I have a swing trade setup signal. I'm looking to enter long if the stock can manage to CLOSE above the last candle high(BUY). If triggered, I will then place a stop-loss below (SL) and a price target above it(TP-50%,move SL to breakeven), then using the close below the 10SMA as my trailing s
Betting on $DOCS: A Technical Analysis Forecasting 8% GrowthNYSE:DOCS shows strong performance with a Relative Strength (RS) rating of 98. The On-Balance Volume (OBV) has been rising since October 1st, indicating ongoing buying interest. The stock is forming a bullish base along the trend line, supported by the 10-day and 20-day Exponential Moving Averages
New Setup: DOCSDOCS: I have a green setup signal(dot Indictor). It has an excellent risk-to-reward ratio(RR:). I'm looking to enter long near the close of the day if the stock can manage to CLOSE above the last candle highs(white line). If triggered, I will then place a stop-loss below(SL) and a price target above
DOCS Doximity Options Ahead of EarningsIf you haven`t bought DOCS before the previous earnings:
Then analyzing the options chain and the chart patterns of DOCS Doximity prior to the earnings report this week,
I would consider purchasing the 25usd strike price Calls with
an expiration date of 2024-6-21,
for a premium of approximately $1
Doximity Surges 18% on Earnings Beat and Strong OutlookDoximity shares ( NYSE:DOCS ) surged 18% after the company beat quarterly earnings forecasts, provided a better-than-expected current-quarter outlook, and unveiled a share buyback program. The provider of curated medical news and telehealth tools reported adjusted earnings of 25 cents per share for
5/16/24 - $docs - not convinced into print, careful fam5/16/24 - vrockstar - NYSE:DOCS - looks modestly interesting b/c the bar looks low-ish for a beat and it's a few days to cover. however, the prior Q's MSD+ revenue beat was sold down hard and without relief until today and the stock divided by SPY (the comp i benchmark everything by) is a bleed fo
cvna has potential to run or to continue the same patternGet ready for another lackluster of action from Carvana stock. the 200 is still settled, 100 moving in the northward direction, but we do see the similarities of the channel on the daily which continues to go up and down like a yo-yo
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of DOCS is 53.21 USD — it has increased by 0.81% in the past 24 hours. Watch Doximity, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Doximity, Inc. stocks are traded under the ticker DOCS.
DOCS stock has fallen by −1.54% compared to the previous week, the month change is a −14.47% fall, over the last year Doximity, Inc. has showed a 111.23% increase.
We've gathered analysts' opinions on Doximity, Inc. future price: according to them, DOCS price has a max estimate of 90.00 USD and a min estimate of 55.00 USD. Watch DOCS chart and read a more detailed Doximity, Inc. stock forecast: see what analysts think of Doximity, Inc. and suggest that you do with its stocks.
DOCS reached its all-time high on Sep 10, 2021 with the price of 107.79 USD, and its all-time low was 19.71 USD and was reached on Sep 25, 2023. View more price dynamics on DOCS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DOCS stock is 3.55% volatile and has beta coefficient of 1.64. Track Doximity, Inc. stock price on the chart and check out the list of the most volatile stocks — is Doximity, Inc. there?
Today Doximity, Inc. has the market capitalization of 9.98 B, it has decreased by −4.26% over the last week.
Yes, you can track Doximity, Inc. financials in yearly and quarterly reports right on TradingView.
Doximity, Inc. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
DOCS earnings for the last quarter are 0.45 USD per share, whereas the estimation was 0.34 USD resulting in a 33.37% surprise. The estimated earnings for the next quarter are 0.27 USD per share. See more details about Doximity, Inc. earnings.
Doximity, Inc. revenue for the last quarter amounts to 168.60 M USD, despite the estimated figure of 152.82 M USD. In the next quarter, revenue is expected to reach 134.02 M USD.
DOCS net income for the last quarter is 75.20 M USD, while the quarter before that showed 44.15 M USD of net income which accounts for 70.30% change. Track more Doximity, Inc. financial stats to get the full picture.
No, DOCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 827 employees. See our rating of the largest employees — is Doximity, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Doximity, Inc. EBITDA is 234.35 M USD, and current EBITDA margin is 38.50%. See more stats in Doximity, Inc. financial statements.
Like other stocks, DOCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Doximity, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Doximity, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Doximity, Inc. stock shows the buy signal. See more of Doximity, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.